{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/43068-304#drug","name":"Hetlioz LQ","alternateName":"tasimelteon","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"43068-304"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA214517"},{"@type":"PropertyValue","propertyID":"UNII","value":"SHS4PU80D9"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"ca4a9b63-708e-49e9-8f9b-010625443b90"}],"activeIngredient":"TASIMELTEON","administrationRoute":["ORAL"],"dosageForm":"SUSPENSION","manufacturer":{"@type":"Organization","name":"Vanda Pharmaceuticals Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA214517","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca4a9b63-708e-49e9-8f9b-010625443b90","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43068-304"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T04:53:43.732Z"}}